Drug Shortage Legislation Gains Momentum With Bipartisan House Bill
Executive Summary
Momentum is increasing for efforts to require manufacturers to give advance warning of a drug shortage with legislation now filed in both houses of Congress.
You may also be interested in...
Compounding Hearings Are First Step In Creating Active Legislative Ingredients
Congress will explore causes and potential policy solutions to the meningitis outbreak at the New England Compounding Center in back-to-back hearings, but any legislation increasing FDA regulatory authority faces a long road.
Drug Shortage Provisions In Draft PDUFA Bill Would Expedite Major Manufacturing Changes
FDA would have 60 days to review major changes and could “deem” them compliant with current good manufacturing practices so long as the facility has a plan and resources to achieve full compliance and institutes quality control measures under draft legislation being developed by the House Energy and Commerce Committee.
Drug Shortage Provisions In Draft PDUFA Bill Would Expedite Major Manufacturing Changes
FDA would have 60 days to review major changes and could “deem” them compliant with current good manufacturing practices so long as the facility has a plan and resources to achieve full compliance and institutes quality control measures under draft legislation being developed by the House Energy and Commerce Committee.